TI - Association of Low Muscle Mass as a Marker of Sarcopenia with Survival in Metastatic Renal Cell Carcinoma Patients Receiving Nivolumab
PT - Journal Article
DP - 2022
TA - EJMI
PG - 374-382
VI - 6
IP - 3
AID - 2022.66227 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2022.66227
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2022 6(3): 374